Mal-amido-PEG2-Val-Cit-PAB-PNP

Mal-amido-PEG2-Val-Cit-PAB-PNP is an advanced heterobifunctional carbohydrate-based linker, specifically engineered to facilitate targeted conjugation strategies in the field of bioconjugate chemistry. Featuring a maleimide group for thiol-selective coupling and a para-nitrophenyl (PNP) ester for amine-reactive conjugation, this compound incorporates a polyethylene glycol (PEG2) spacer and a valine-citrulline (Val-Cit) dipeptide sequence, further appended with a p-aminobenzyl (PAB) self-immolative linker. The rational design of Mal-amido-PEG2-Val-Cit-PAB-PNP enables it to serve as a versatile and modular tool for constructing cleavable linkages between biomolecules, small molecules, and polymers. Its unique architecture supports site-specific attachment, controlled release, and improved aqueous solubility, making it highly valuable for research and development in advanced drug delivery, diagnostics, and chemical biology. The presence of the Val-Cit dipeptide provides a protease-sensitive cleavage site, while the PAB moiety ensures efficient payload release upon enzymatic activation, collectively offering precise control over conjugate stability and release kinetics.

Antibody-Drug Conjugate (ADC) Development: Mal-amido-PEG2-Val-Cit-PAB-PNP is extensively utilized in the synthesis of antibody-drug conjugates, where its maleimide and PNP ester functionalities enable orthogonal conjugation of cytotoxic payloads to monoclonal antibodies. The Val-Cit-PAB sequence is specifically recognized and cleaved by cathepsin B and related lysosomal proteases, which are frequently upregulated in tumor microenvironments. Upon internalization into target cells, the linker undergoes enzymatic cleavage, resulting in self-immolation of the PAB group and subsequent release of the active drug. This mechanism provides enhanced selectivity and minimizes off-target effects, supporting the rational design of next-generation ADCs for precise cell targeting and controlled drug release.

Targeted Protein Modification: In protein engineering and functionalization studies, this bifunctional linker enables site-specific modification of proteins through selective reaction with accessible thiol and amine groups. The PEG2 spacer imparts flexibility and reduces steric hindrance, preserving protein activity and improving solubility. Researchers can exploit the orthogonal reactivity to attach fluorescent probes, affinity tags, or other functional moieties, facilitating downstream applications such as protein tracking, purification, and interaction analysis. The cleavable Val-Cit-PAB motif allows for controlled release of the attached group in response to protease activity, which is especially useful in studies requiring reversible labeling or triggered payload delivery.

Polymer-Drug Conjugation: The unique structure of Mal-amido-PEG2-Val-Cit-PAB-PNP supports its use in the assembly of polymer-drug conjugates, where it acts as a cleavable linker between hydrophilic polymers and therapeutic agents. The PEG2 segment enhances aqueous solubility and biocompatibility, while the protease-sensitive Val-Cit linker provides stimulus-responsive drug release. By integrating this linker into polymeric delivery systems, researchers can achieve tunable pharmacokinetics, improved drug stability, and targeted release in environments with elevated protease activity, such as inflamed or diseased tissues.

Diagnostic Probe Construction: In the field of molecular diagnostics, the linker's orthogonal reactivity and cleavable properties are leveraged to construct sensitive and specific diagnostic probes. By conjugating imaging agents, reporters, or biosensors to antibodies, peptides, or other targeting molecules, it is possible to create probes that remain inactive until encountering disease-associated proteases. Upon cleavage, the PAB self-immolative group ensures rapid and efficient signal generation, thereby enhancing the sensitivity and specificity of diagnostic assays for biomarker detection in complex biological samples.

Bioconjugate Research Tools: Mal-amido-PEG2-Val-Cit-PAB-PNP also serves as a valuable research tool for developing and optimizing novel bioconjugate platforms. Scientists utilize its modular design to explore structure-activity relationships, study enzymatic cleavage kinetics, and evaluate the impact of linker chemistry on the stability and function of conjugates. The ability to fine-tune the linker's properties through PEG length, dipeptide sequence, and self-immolative chemistry supports innovation across a broad spectrum of chemical biology and materials science applications, advancing the development of smarter, more responsive molecular constructs.

The versatility of Mal-amido-PEG2-Val-Cit-PAB-PNP positions it as a foundational component in the toolkit of researchers working in antibody-drug conjugate development, targeted protein modification, polymer-drug conjugation, diagnostic probe construction, and bioconjugate research. Its unique combination of orthogonal reactivity, cleavable linker design, and modular architecture facilitates precise control over conjugation and release processes, supporting a wide array of experimental strategies in modern chemical biology, drug delivery, and diagnostic innovation.

1. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors

2. cRGD-functionalized, DOX-conjugated, and 64Cu-labeled superparamagnetic iron oxide nanoparticles for targeted anticancer drug delivery and PET/MR imaging

3. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists

4. Myotropic activity of allatostatins in tenebrionid beetles

5. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate